COMMUNIQUÉS West-GlobeNewswire

Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss Second Quarter Financial Results on September 10, 2017

07/11/2017 - 14:00

NORTHVALE, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent opioids and niche [...]

Immune Design Announces Multiple Presentations at CTOS and SITC Highlighting the Breadth of Existing & Future Product Candidates

07/11/2017 - 14:00

SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ ), a clinical-stage immunotherapy company focused on oncology, today announced seven presentations at the upcoming [...]

Atara Biotherapeutics to Participate in Four Upcoming Investor Conferences

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Chalice Farms Announces New Seasonal Cannabis Edibles

07/11/2017 - 14:00

Portland, Oregon-based dispensary chain, part of the Golden Leaf Holdings portfolio of brands, unveils line of Pumpkin Spice Cannabis Truffles and Cannabis-Infused Dark Chocolate Peppermint for fall and holiday season

Proteon Therapeutics Announces Third Quarter 2017 Financial Results

07/11/2017 - 14:00

WALTHAM, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO ), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney and vascular [...]

Chimerix to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

DURHAM, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX ), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H., [...]

Cannabix Technologies Files THC Based Ignition Interlock Patent Application and Provides Update on Marijuana Breathalyzer Development

07/11/2017 - 14:00

VANCOUVER, British Columbia, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and [...]

Neos Therapeutics to Present at the Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

DALLAS/FORT WORTH, Texas, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing, and commercializing innovative extended-release (XR) [...]

CRISPR Therapeutics to Present New Data on Allogeneic CRISPR-based CAR-T Program and Host Investor Reception at the 32nd Annual Society for Immunotherapy of Cancer Meeting

07/11/2017 - 14:00

ZUG, Switzerland and CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a genome editing company focused on creating transformative medicine for serious diseases, today announced [...]

OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform

07/11/2017 - 14:00

MIAMI, Nov. 07, 2017 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) ("OPKO" or "the Company") announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the [...]

G1 Therapeutics to Present at Stifel 2017 Healthcare Conference

07/11/2017 - 14:00

RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (NASDAQ: GTHX ), a clinical-stage oncology company, announced today that Chief Executive Officer Mark Velleca, MD, PhD, will present [...]

Portola Pharmaceuticals Announces New APEX Study Sub-Analyses Data on Betrixaban to be Presented at the America Heart Association (AHA) Scientific Sessions 2017

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals Inc. ® (Nasdaq: PTLA ) today announced that results of new sub-analyses of the APEX Study of betrixaban will be presented in oral [...]

Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017

07/11/2017 - 14:00

SAN DIEGO and TORONTO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Aptose) (NASDAQ: APTO ) (TSX: APS ), a clinical-stage company developing highly differentiated therapeutics targeting the underlying [...]

Spring Bank to Present at Piper Jaffray’s 29th Annual Healthcare Conference

07/11/2017 - 14:00

HOPKINTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ: SBPH ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]

Five Prime Therapeutics to Host Conference Call on November 11th to Review Cabiralizumab Phase 1a/1b Data to be Presented in Late Breaking Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

07/11/2017 - 14:00

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (NASDAQ: FPRX ), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology [...]

DiaMedica Therapeutics Announces Publication of Positive Clinical Results for DM199 in the International Journal of Clinical Trials

07/11/2017 - 14:00

MINNEAPOLIS, Nov. 07, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company focused on improving the lives of patients with [...]

Krystal Biotech’s KB103 Granted Orphan Drug Designation by the FDA to Treat Patients With Dystrophic Epidermolysis Bullosa

07/11/2017 - 14:00

PITTSBURGH, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (Nasdaq: KRYS ), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological [...]

Jounce Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

07/11/2017 - 14:00

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]

Alimera Sciences' CEO Dan Myers to Present During Ophthalmology Innovation Summit at American Academy of Ophthalmology 2017

07/11/2017 - 13:30

ATLANTA, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in the commercialization and development of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, [...]